Results 191 to 200 of about 22,583 (294)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board. [PDF]

EJNMMI Radiopharm Chem
Spreckelmeyer S, Dasilva J, Decristoforo C, Mach RH, Passchier J, Carlucci G, Qhatani MA, Duatti A, Cornelissen BT, Engle J, Denkova A, Hendrikx JJMA, Seimbille Y, Yang X, Jia H, Zhang MR, Yang M, Perk L, Caravan P, Laverman P, Cheng Z, Hoehr C, Sakr T, Zeevaart JR.   +23 more
europepmc   +1 more source

3.Environmental Safety after Administration of Radiopharmaceuticals(Panel Discussion Public Radioprotection)

, 1997
TOMIO NAKAJU
openalex   +2 more sources

Evolution of radiopharmaceuticals for diagnosis and therapy [PDF]

, 2002
Susan Z. Lever
openalex   +1 more source

Diagnosis of Bone Metastasis due to Medullary Thyroid Cancer With ^99mTc- (V) DMSA SPECT Imaging. [PDF]

Clin Case Rep
Gharepapagh E, Houshyar J, Mamaghani FF, Karbasi M, Rezaei S.   +4 more
europepmc   +1 more source

Radiopharmaceuticals for Targeted Tumor Diagnosis and Therapy

, 2000
Robert Waibel, Ilse Novak‐Hofer, Roger Schibli, Peter Bläuenstein, Elisa García‐Garayoa, R. Schwarzbach, Kurt Zimmermann, Raimo Pellikka, Olga Gasser, Alain Blanc, Matthias Brühlmeier, P. August Schubiger   +11 more
openalex   +2 more sources

Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy. [PDF]

EJNMMI Res
Heilinger J, Roth KS, Weis H, Fink A, Weindler J, Dietlein F, Krapf P, Schomäcker K, Neumaier B, Dietlein M, Drzezga A, Kobe C.   +11 more
europepmc   +1 more source

Radiopharmaceutical Chemistry in Peking University (PKU)

, 2000
Xiangyun Wang, Yonghui Wu, Wang Yi, Yuanfang Liu   +3 more
openalex   +2 more sources

Molecular Imaging of Paragangliomas and Pheochromocytomas. [PDF]

Radiol Imaging Cancer
Burkett BJ, Johnson DR.
europepmc   +1 more source

Identification of Coronary Thrombus With a IIb/IIIa Platelet Inhibitor Radiopharmaceutical, Technetium-99m DMP-444

, 2000
Joseph F. Mitchel, David D. Waters, Tianjie Lai, Michael J. White, Tod Alberghini, Ahmad Salloum, David R. Knibbs, Dadong Li, Gary V. Heller   +8 more
openalex   +1 more source

Long-Term Safety and Survival Outcomes of [²²⁵Ac]Ac-PSMA (Prostate-Specific Membrane Antigen) and [²²⁵Ac]Ac-/[¹⁷⁷Lu]Lu-PSMA (TANDEM) Radioligand Therapy (PRLT) in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancers (Basel)
Perrone E, Giordano A, Calcagni ML, Leccisotti L, Moretti R, Eismant A, Ghai K, Parkar T, Mishra A, Heidenreich A, Wirtz RM, Müller J, Greifenstein L, Baum RP.   +13 more
europepmc   +1 more source